Evidence map›Paper›PMID 31856265›Full record

ArticlePloS one2019

Healthcare utilization and costs of cardiopulmonary complications following cardiac surgery in the United States.

Mitali Stevens, Apeksha V Shenoy, Sibyl H Munson, Halit O Yapici, Boye L A Gricar, Xuan Zhang, Andrew D Shaw

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mitali StevensGlobal Health Economics & Reimbursement, Edwards Lifesciences, Irvine, California, United States of America.
Apeksha V ShenoyDepartment of Health Economics and Outcomes Research, Boston Strategic Partners, Inc., Boston, Massachusetts, United States of America.
Sibyl H MunsonDepartment of Health Economics and Outcomes Research, Boston Strategic Partners, Inc., Boston, Massachusetts, United States of America.
Halit O YapiciDepartment of Health Economics and Outcomes Research, Boston Strategic Partners, Inc., Boston, Massachusetts, United States of America.
Boye L A GricarDepartment of Health Economics and Outcomes Research, Boston Strategic Partners, Inc., Boston, Massachusetts, United States of America.
Xuan ZhangDepartment of Health Economics and Outcomes Research, Boston Strategic Partners, Inc., Boston, Massachusetts, United States of America.
Andrew D ShawDepartment of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-0566-8005
Edwards Lifesciences (United States) · USUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study examined postoperative heart failure (HF) and respiratory failure (RF) complications and related healthcare utilization for one year following cardiac surgery.

methodsThis study identified adult patients undergoing isolated coronary artery bypass graft (CABG) and/or valve procedures from the Cerner Health Facts® database. It included patients experiencing postoperative HF or RF complications. We quantified healthcare utilization using the frequency of inpatient admissions, emergency department (ED) visits with or without hospital admission, and outpatient visits. We then determined direct hospital costs from the determined healthcare utilization. We analyzed trends over time for both HF and RF and evaluated the association between surgery type and HF complication.

resultsOf 10,298 patients with HF complications, 1,714 patients (16.6%) developed persistent HF; of the 10,385 RF patients, 175 (1.7%) developed persistent RF. Healthcare utilization for those with persistent complications over the one-year period following index hospital discharge comprised an average number of the following visit types: Inpatient (1.49 HF; 1.55 RF), Outpatient (2.02, 0.51), ED without hospital admission (0.33, 0.13), ED + Inpatient (0.08, 0.06). Per patient annual costs related to persistent complications of HF and RF were $20,857 and $30,745, respectively. There was a significant association between cardiac surgical type and the incidence of HF, with risk for isolated valve procedures (adjusted OR 2.60; 95% CI: 2.35-2.88) and CABG + valve procedures (adjusted OR 2.38; 95% CI: 2.17-2.61) exceeding risk for isolated CABG procedures.

conclusionsThis study demonstrates that HF and RF complication rates post cardiac surgery are substantial, and complication-related healthcare utilization over the first year following surgery results in significant incremental costs. Given the need for both payers and providers to focus on healthcare cost reduction, this study fills an important gap in quantifying the mid-term economic impact of postoperative cardiac surgical complications.

Indexed as

Costs and Cost AnalysisAdolescentAdultAgedCardiac Surgical ProceduresFemaleHeart FailureHumansMaleMiddle AgedPostoperative ComplicationsProcedures and Techniques UtilizationRespiratory InsufficiencyUnited States

Identifiers

PMID31856265
PMCPMC6922411
OpenAlexW2996547717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.